insights_auto
Why is CMXHF up 2,22%?
Dive Deeperchevron_right
CMXHF:OTCMKTS
CSL Ltd
123,79 US$
arrow_upward
+2,22%(+2,69) 1D
15 ოქტ, 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CMXHF...
Open
129,22 US$
High
129,22 US$
Low
123,79 US$
Mkt. cap
92,23 მლრდ.
Avg. vol.
167,00
Volume
564,00
52-wk high
148,36 US$
52-wk low
63,84 US$
Beta
0,56
Shares outstanding
479,88 მლნ.
No. of employees
29 ათ.
Open
129,22 US$
High
129,22 US$
Low
123,79 US$
Mkt. cap
92,23 მლრდ.
Avg. vol.
167,00
Volume
564,00
52-wk high
148,36 US$
52-wk low
63,84 US$
Beta
0,56
Shares outstanding
479,88 მლნ.
No. of employees
29 ათ.
News stories
From web sources and news partners
ad-hoc-news.de
·
1 დღის წინ
CSL agrees Alentis drug deal as CSL stock has AUD 89.7 billion value
Profile
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994. Wikipedia
About CSL Ltd
CEOპოლ მაკ-კენზი
Employees29 ათ.
Founded1916
Headquartersმელბურნი, ვიქტორიას შტატი, ავსტრალია
Sector-
Websitecsl.com